Vaxart Inc.'s (VXRT) shares closed 11.1% higher on August 2, and then rose another 2.1% in pre-market trading on August 3. The stock price moved after the clinical-stage biotechnology company got the U.S. Food and Drug Administration's (FDA) nod for its Investigational New Drug (IND) application for the S-only oral tablet SARS-CoV-2 vaccine candidate. Encouraged by the FDA approval, Vaxart CEO Andrei Floroiu said, “This is great news because it allows us to move forward with our first S-only vaccine construct.
https://www.tipranks.com/news/fda-approves-ind-for-vaxarts-oral-tablet-shares-rise?utm_source=advfn.com&utm_medium=referral
Vaxart (NASDAQ:VXRT)
Historical Stock Chart
From Aug 2021 to Sep 2021 Click Here for more Vaxart Charts.
Vaxart (NASDAQ:VXRT)
Historical Stock Chart
From Sep 2020 to Sep 2021 Click Here for more Vaxart Charts.